http://www.legislation.gov.uk/uksi/2019/744/regulation/6
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
text
text/xml
en
EXITING THE EUROPEAN UNION
MEDICINES
Statute Law Database
2024-05-16
Expert Participation
2020-12-31
These Regulations are made in exercise of the powers conferred by section 8(1) of the European Union (Withdrawal) Act 2018 (c. 16) and amend the Medicines for Human Use (Clinical Trials) Regulations 2004 in order to address failures of retained EU law to operate effectively and other deficiencies (in particular under section 8(2)(a), (b), (c), (d), (f) and (g) and (6)) arising from the withdrawal of the United Kingdom from the European Union.
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
Omission of regulation 4 (responsibility for functions under the Directive)I16
Omit regulation 4 M1.